MicroRNA in women with toxoplasmosis and mental illness
Part of Infections clinical trials.
This study looks at tiny molecules in the blood (called microRNAs) that might help doctors tell the difference between mental health conditions in women who have had a past infection with the parasite Toxoplasma. The goal is to find better ways to diagnose and treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia, major depressive disorder, or bipolar disorder
- You have had a past infection with toxoplasmosis (not a current active infection)
- You are willing to sign a consent form
- You do not have other mental health conditions besides those listed
- You are not currently experiencing an active toxoplasma infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have a positive toxoplasma blood test (PCR) but no symptoms. It aims to learn more about what this finding means and how it should be treated.
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
This study tests a combination of three medications (pyrimethamine, sulfadiazine, and leucovorin) to treat toxoplasmosis—a parasitic infection passed from mother to baby during pregnancy. The goal is to see if early treatment prevents serious complications in infected infants.
This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.
This study looks at how certain molecules (called non-coding RNAs) relate to mental health conditions like bipolar disorder, depression, anxiety, OCD, or schizophrenia. By comparing patients who haven't been on psychiatric medication for at least 6 months with healthy volunteers, researchers hope to find better ways to diagnose and understand these conditions.
This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.
Hear when a new Toxoplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.